Pain Management
Foundations of Pain Management
Introduction to Pain Reality: * Pain is a primary reason individuals seek healthcare services. * Consequences of Untreated Pain: * Unnecessary suffering. * Physical and psychosocial dysfunction. * Immunosuppression. * Sleep disturbances.
Standardized Definitions of Pain: * Margo McCaffery Definition: "Whatever the person experiencing pain says it is, existing whenever the person says it does." * IASP (International Association for the Study of Pain) Definition: "Unpleasant sensory and emotional experience associated with actual or potential tissue damage."
Common Patient-Related Barriers: * Fear of addiction to drugs. * Belief that drugs should be saved for when they are "really needed." * Concerns regarding unpleasant or dangerous side effects. * Misconception that pills are less effective than injections (shots). * Belief that narcotics are reserved only for patients who are dying.
Responses to Pain: * Emotional Responses: Anger, fear, depression, and anxiety. * Behavioral Responses: Grimacing, irritability, and agitation. * Coping-Related Behaviors: Combativeness and specific coping skills.
Classification and Categories of Pain
Classification by Underlying Pathology: * Nociceptive Pain: * Origin: Arises from damage to or inflammation of tissue. * Characteristics: Described as throbbing, aching, and is typically localized. * Treatment: Usually responds well to opioid and nonopioid medications. * Neuropathic Pain: * Origin: Arises from abnormal or damaged pain nerves. * Characteristics: Described as intense, shooting, burning, or a "pins and needles" sensation. * Treatment: Responds typically to adjuvant medications, such as antidepressants, antispasmodic agents, and skeletal muscle relaxants.
Classification by Duration: * Acute Pain (Transient): * Nature: Protective, temporary, self-limiting. * Etiology: Direct cause such as acute injury, disease, surgical pain, traumatic pain (e.g., broken bones, cuts, burns), or muscle strain. * Duration: Lasts from days up to, but not longer than, months. * Resolution: Occurs when the underlying cause is treated or healed. * Physiological Signs: Tachycardia, hypertension, anxiety, diaphoresis, and muscle tension. * Behavioral Signs: Grimacing, moaning, flinching, and guarding. * Therapeutic Goal: Relief that enables recovery participation, prevents complications, and improves functional status. * Chronic Pain (Persistent): * Nature: Not protective; ongoing or frequently recurring. * Duration: Lasts longer than months and persists beyond expected tissue healing. * Etiology: Health conditions such as arthritis, low back pain, headache, fibromyalgia, peripheral neuropathy, or spinal conditions. * Physiological Signs: Vital signs do not usually alter significantly. * Behavioral Signs: Decreased level of functioning, fatigue, insomnia, anorexia, weight loss, apathy, hopelessness, depression, and anger. * Therapeutic Goal: Improve functional status using a multimodality plan.
The Nursing Process in Pain Management
Guiding Principles: * Management must be systematic. * The patient's self-report is the most reliable diagnostic measure. * Pain must be assessed as the "5th vital sign" frequently.
Nursing Process Stages: * Assessment: Focused data collection. * Nursing Diagnosis: Categorization of data (e.g., Acute pain, Chronic pain, Impaired physical mobility, Activity intolerance, Anxiety, Risk for injury). * Planning: Identification of patient-centered goals (e.g., "The patient will achieve an acceptable level of pain relief within hours"). * Implementation: Initiation of individualized interventions. * Evaluation: Analysis of intervention effectiveness.
Nurse Attitudes and Beliefs: * Nurses must reflect on personal beliefs and ensure they do not negatively affect management. * Care must be based on patient needs and professional evidence-based standards.
Comprehensive Pain Assessment
Symptom Analysis Components: * Location: Use anatomical landmarks. Include distinctions for: * Referred Pain: Perceived at a location other than the site of origin (e.g., myocardial infarction felt in the jaw/left arm; kidney stones felt in the groin). * Radiating Pain: Sensation extends from the initial site to another part (e.g., sciatica moving from lower back down the legs). * Quality: Character of pain (e.g., sharp, dull, burning, stabbing, crushing). * Intensity: Measurement using scales (e.g., scale, FACES scale). * Timing: Onset (sudden vs. gradual), duration (constant vs. intermittent), and frequency. * Setting: Impact on ADLs and how ADLs affect pain. * Aggravating/Relieving Factors: What makes pain worse or better (e.g., movement, coughing, ice packs, rest).
Breakthrough Pain (BTP): * Defined as a sudden increase in pain in patients with existing chronic pain. * Transends the routine medication management ("breaks through"). * Common in cancer, arthritis, and fibromyalgia.
Pain Intensity Scales: * Numerical Rating Scale (NRS): Rating from (no pain) to (worst possible pain). * Simple Descriptive Scale: No pain, mild, moderate, severe, very severe, worst possible. * Wong-Baker FACES: Used for nonverbal patients or children, matching faces to pain levels.
Pasero Opioid-Induced Sedation Scale (POSS): * S: Sleep, easy to arouse (Acceptable). * 1: Awake and alert (Acceptable). * 2: Slightly drowsy, easily aroused (Acceptable). * 3: Frequently drowsy, arousable, drifts off during conversation (Unacceptable). * 4: Somnolent, minimal/no response to stimuli (Unacceptable).
Intervention Strategies
Nonpharmacological Interventions: * Physical: Positioning (turn schedules), gentle massage, Physical Therapy (Active/Passive ROM), and TENS (Transcutaneous Electrical Nerve Stimulation). * Psychological/Cognitive: Relaxation techniques, guided imagery, distraction, and spiritual support. * Others: Pet therapy, acupuncture, and thermal therapy (gel packs, warm/cool compresses).
Pharmacological Management:
* Nonopioid Analgesics (e.g., acetaminophen, ibuprofen): * Mechanism: Reduce prostaglandin production. * Analgesic Ceiling: Increasing the dose beyond a certain limit provide no additional relief. * Safety: Do not produce tolerance or physical dependence. * Acetaminophen (Tylenol): Hepatotoxic risk; limit to . Available parenterally. * NSAIDs (Ibuprofen/Advil): Risk of GI bleeding and ulceration. Requires caution in liver disease/hepatitis. Monitor renal/liver labs.
* Opioid Agonist Analgesics (e.g., oxycodone, morphine): * Mechanism: Bind to CNS receptors to block pain signals. * Routes: IV is best for immediate relief. PCA (Patient Controlled Analgesia) allows patient-managed dosing. * Risks: Respiratory depression (highest risk in opioid-naïve patients), constipation, nausea/vomiting, sedation, and pruritus. * Antidote: Narcan (naloxone) is the antagonist for rapid reversal; administer if Respiratory Rate (RR) is < .
* Agonist-Antagonist (e.g., butorphanol): * Have an analgesic ceiling. * May cause withdrawal in opioid-dependent patients.
* Adjuvant Analgesics: * Used alone or with opioids to enhance effects or treat neuropathic pain. * Examples: Anticonvulsants (gabapentin), antidepressants (amitriptyline), glucocorticoids (dexamethasone), and antihistamines (hydroxyzine).
* Cannabinoids (Cannabis): * THC: Psychoactive component; effective for pain and nausea. * CBD: Non-psychoactive; used for inflammation/seizures. * Interactions: Increases warfarin levels (bleeding risk). Serious sedation with ETOH or opioids. Can lower blood sugar.
Evaluation and Documentation
Reassessment Timing (by Route): * IV: minutes post-administration. * IM: minutes post-administration. * PO: minutes post-administration. * General requirement: Full evaluation within minutes.
Prevention of Complications: * Undertreatment leads to anxiety (acute) and depression (chronic). * Constant pain requires Around-The-Clock (ATC) administration, not PRN. * Incorporate caregiver teaching and manage side effects proactively.